http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A protein – already known to be involved in a cell's response to stress – called Tetratricopeptide repeat domain 5 (TTC5) is critical to the development of acute myeloid leukaemia (AML), according to a new Cancer Research UK study published in Cell Death and Disease. http://medicalxpress.com/news/2013-04-protein-dna-critical-leukaemia-cell.html Cancer Fri, 05 Apr 2013 06:23:42 EST news284361744 University of New South Wales researchers have developed a compound that has had a surprise result: being effective in the prevention of asthma. http://medicalxpress.com/news/2013-01-reversing-symptoms-asthma.html Inflammatory disorders Tue, 22 Jan 2013 06:28:47 EST news278058507 Survival for people diagnosed with Chronic Myeloid Leukaemia (CML) has risen by nearly half, with around 58 per cent of people surviving their disease for at least five years compared with only around 40 per cent in the late 1990s, according to a new report from the National Cancer Intelligence Network (NCIN), published today. http://medicalxpress.com/news/2012-12-treatments-chronic-myeloid-leukaemia-survival.html Cancer Wed, 12 Dec 2012 08:05:52 EST news274521939 Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date. http://medicalxpress.com/news/2012-12-positive-early-results-clinical-trial.html Cancer Fri, 07 Dec 2012 11:50:06 EST news274100504 Many observational epidemiologic studies have found an inverse association between alcohol consumption and hematological cancers (such as lymphoma and leukemia). This study, based on the Million Women's Study in the UK, is large enough to permit an evaluation of associations with various types of such cancers. Further, it takes into account newer coding systems for morphology so that diseases associated with the lymphatic system can be separated from those of the myeloid system. http://medicalxpress.com/news/2012-11-effects-alcohol-lymphoma-leukemia-hematological.html Cancer Tue, 13 Nov 2012 13:12:38 EST news272034674 (Medical Xpress)—Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease, results from a major phase III Cancer Research UK-funded trial led by Cardiff University show today. http://medicalxpress.com/news/2012-11-antibody-conjugate-drug-survival-older.html Cancer Mon, 12 Nov 2012 09:40:01 EST news271934631 Leading scientists in the field investigated the potential of RNA interference (RNAi) technology as a therapeutic intervention for down-regulating the expression of disease-associated genes. Project deliverables hold significant exploitation ground in research and medicine. http://medicalxpress.com/news/2012-09-rna-human-therapy.html Medical research Thu, 20 Sep 2012 13:04:07 EST news267365041 (Medical Xpress) -- Scientists in a team at Newcastle University have identified a mechanism by which treatment-related leukaemia develops, raising hopes that this side effect of toxic chemotherapy could be prevented. http://medicalxpress.com/news/2012-05-scientists-common-treatment-related-cancer.html Cancer Thu, 31 May 2012 07:40:53 EST news257668842 Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. These are the conclusions of an Article published Online First by The Lancet, written by Professor Sylvie Castaigne, Centre Hospitalier de Versailles, France, and colleagues. http://medicalxpress.com/news/2012-04-fractionated-dosing-regimen-anticancer-drug.html Cancer Wed, 04 Apr 2012 18:30:01 EST news252768318 (Medical Xpress) -- Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival, according to research published in Cancer Cell today. http://medicalxpress.com/news/2012-03-scientists-drug-hard-to-treat-leukaemia.html Cancer Fri, 30 Mar 2012 07:03:35 EST news252309793 Melbourne researchers have discovered that acute myeloid leukaemia (AML), an aggressive blood cancer with poor prognosis, may be susceptible to medications that target a protein called Mcl-1. http://medicalxpress.com/news/2012-01-cell-death-achilles-heel-acute.html Genetics Tue, 17 Jan 2012 10:43:03 EST news246019373